✦ LIBER ✦

1024 Etoposide, platinum, ifosfamide and dexamathasone (EPID) as second line treatment in patients with non-Hodgkin's lymphoma (NHL)

✍ Scribed by Aldaco, F.; Gomez, A.; Cerna, M.; Vazquez, L.; Valdez, M.; Sanchez, G.; Erazo, A.; Cervantes, G.; Torrecillas, L.; Cortes, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dexamethasone, etoposide, ifosfamide, an

✍ Nissim Haim; Menachem Ben-Shahar; David Faraggi; Avital Tsuri-Etzioni; Michelle 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. This study analyzed the long term results of a combination of dexa-

810 Dexamethasone, etoposide, ifosfamide

✍ N. Haim; M. Ben-Shahar; R. Epelbaum; E. Robinson 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Plerixafor as First- and Second-Line Str

✍ Kevin W. Lor; Pieter J. Helmons; Helen Belew; James R. Lane; Edward D. Ball 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

PCN29 COST-EFFECTIVENESS OF MAINTENANCE

✍ F Kasteng; M Erlanson; H Hagberg; E Kimby; T Relander; J Lundkvist 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB